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Summary 
Tyrosine phosphorylation of ß-catenin, a component of adhesion complexes and the 
Wnt pathway, affects cell adhesion, migration and gene transcription. By reducing ß-
catenin availability using shRNA-mediated gene silencing or expression of intracellular 
N-cadherin, we show that ß-catenin is required for axon growth downstream of Brain 
Derived Neurotrophic Factor (BDNF) and Hepatocyte Growth Factor (HGF) signalling. 
We demonstrate that receptor tyrosine kinases (RTK) Trk and Met interact with and 
phosphorylate ß-catenin. Neurotrophins (NT) stimulation of Trk receptors results in 
phosphorylation of  ß-catenin at residue Y654 and increased axon growth and 
branching. Conversely, pharmacological inhibition of Trk or a Y654F mutant blocks 
these effects. ß-catenin phospho(P)-Y654 colocalizes with the cytoskeleton at growth 
cones. However, HGF that also increases axon growth and branching, induces ß-catenin 
phosphorylation at Y142 and a nuclear localization. Interestingly, dominant negative 
∆N-TCF4 abolishes the effects of HGF in axon growth and branching,  but not of NT. 
We conclude that NT and HGF signalling differentially phosphorylate ß-catenin, 
targeting ß-catenin to distinct compartments to regulate axon morphogenesis by TCF4-
transcription-dependent and independent mechanisms. These results place ß-catenin 
downstream of growth factor/RTK signalling in axon differentiation.  
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Introduction    
The establishment of proper neuronal connections is crucial to brain physiology and 
requires the outgrowth and arborization of axons and dendrites, before synaptic contacts 
are stabilized. Both extracellular cues and an intrinsic cell program promote neuronal 
polarity and axon growth (Arimura and Kaibuchi, 2007). A variety of extracellular 
signals play a major role in neuronal differentiation and synapse formation (Arimura 
and Kaibuchi, 2007; Ciani and Salinas, 2005; Dalva et al., 2007; Huang and Reichardt, 
2001; Takeichi, 2007). NT and their Trk receptors are among the best-known regulators 
of neuronal development and function (Chao, 2003; Huang and Reichardt, 2001; Huang 
and Reichardt, 2003; Zampieri and Chao, 2006). TrkB and TrkC are expressed in the 
hippocampus and their ligands BDNF, NT-3 and NT-4 regulate neurite outgrowth and 
branching in hippocampal neurons (Collazo et al., 1992; Labelle and Leclerc, 2000; 
Lindholm et al., 1996; Martinez et al., 1998; Vicario-Abejon et al., 1998). HGF and its 
RTK Met are also expressed in the hippocampus where HGF is a neurotrophic factor for 
hippocampal neurons (Honda et al., 1995; Korhonen et al., 2000). Furthermore, Wnt 
factors regulate neuronal differentiation through different signalling pathways (Ciani 
and Salinas, 2005). Despite the abundance of molecules controlling neuronal 
morphogenesis, the intracellular mechanisms that integrate these signals to define the 
morphology of the neuritic arbour are poorly understood.     
 
ß-catenin is a cytoplasmatic protein that plays a critical role in calcium-dependent cell-
cell adhesion and Wnt signalling (Lilien and Balsamo, 2005; Nelson and Nusse, 2004). 
As a component of the adhesion complex, ß-catenin binds to the intracellular domain of 
cadherins and to α-catenin, which in turn can bind to actin (Drees et al., 2005; Yamada 
et al., 2005). In the canonical Wnt pathway, Wnts inhibit Glycogen Synthase Kinase-3ß 
(GSK-3ß) that targets ß-catenin for degradation, resulting in ß-catenin nuclear 
translocation and activation of T Cell Factor/Lymphoid Enhancing Factor (TCF/LEF)-
driven gene transcription (Ciani et al., 2004; Ciani and Salinas, 2005; Logan and Nusse, 
2004; Nelson and Nusse, 2004).  
 
The regulation of cell adhesion underlies important processes such as neurite extension, 
synaptogenesis, cell migration and epithelial-mesenchymal transition in development 
 4
and metastasis (Brembeck et al., 2006; Dalva et al., 2007; Nelson and Nusse, 2004; 
Takeichi, 2007; Thiery, 2002). Tyrosine phosphorylation of ß-catenin by RTK is known 
to alter cell adhesion (Nelson and Nusse, 2004; Lilien and Balsamo, 2005). For 
example, the EGF receptor (EGFR) associates with ß-catenin in the core region which 
contains residue Y654 and induces ß-catenin phosphorylation (Hoschuetzky et al., 
1994; Takahashi et al., 1997), resulting in decreased affinity for cadherin (Hoschuetzky 
et al., 1994; Nelson and Nusse, 2004; Roura et al., 1999; Takahashi et al., 1997). 
Similarly, in epithelial cells phosphorylation of Y142 by non-receptor tyrosine kinases 
Fer, Fyn or RTK Met weakens the binding of ß-catenin to α-catenin (Brembeck et al., 
2004; Lilien and Balsamo, 2005; Nelson and Nusse, 2004; Piedra et al., 2001). 
Activation of ß-catenin signalling by Met and phosphorylation of ß-catenin Y142 leads 
to its nuclear translocation and increased TCF-mediated gene transcription (Brembeck 
et al., 2004; Danilkovitch-Miagkova et al., 2001). In addition, Fer interacts with 
cadherin indirectly and phosphorylates PTP1B, regulating PTP1B binding to cadherin 
and the continuous dephosphorylation of ß-catenin Y654 (Balsamo et al., 1998; 
Balsamo et al., 1996; Piedra et al., 2003; Xu et al., 2002; Xu et al., 2004). Together, the 
available data indicates that the tyrosine phosphorylation state of ß-catenin, resulting 
from the balance of phosphatase and kinase activities, regulates cell migration by 
decreasing adhesion and activating ß-catenin signalling in epithelial tissue.  
 
In the nervous system, cadherin and ß-catenin regulate axon extension (Riehl et al., 
1996), dendritogenesis (Yu and Malenka, 2003), synaptic assembly and plasticity 
(Bamji, 2005; Bamji et al., 2006; Tai et al., 2007; Yu and Malenka, 2003). Interestingly, 
tyrosine phosphorylation of ß-catenin also regulates synapse formation and function 
(Bamji et al., 2006; Murase et al., 2002) and the growth cone response to the guidance 
cue Slit (Rhee et al., 2007; Rhee et al., 2002).  
 
In this paper we have investigated the relationship between ß-catenin and growth 
factor/RTK signalling in axon morphogenesis. We find that ß-catenin is required for 
axon extension. Stimulation of neuronal RTK, Trk and Met by NTs and HGF results in 
ß-catenin tyrosine phosphorylation. ß-catenin phosphorylation at Y654 by BDNF or 
NT-3 signalling increases axon growth and branching in hippocampal neurons, whereas 
the mutant Y654F or Trk inhibition abolishes the NT effects. We also demonstrate that 
HGF stimulates axon growth and branching by phosphorylating ß-catenin at Y142. 
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Finally, we present evidence suggesting that the regulation of axon morphogenesis by 
NT and P-Y654 ß-catenin occurs independently of TCF4. In contrast, Met activation 
results in P-Y142 ß-catenin nuclear localization and TCF4-mediated gene transcription 
to promote axon growth and branching. Our results identify a crosstalk between ß-
catenin and growth factor signalling networks during axon morphogenesis. 
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Results 
Trk interacts with ß-catenin 
ß-catenin has been shown to associate with and to be a substrate of EGFR (Hoschuetzky 
et al., 1994; Takahashi et al., 1997). Here we explored whether it interacts with other 
RTK such as Trk in neuronal cell lines and primary neurons. PC12 6/15 cells, a clone of  
PC12 cells stably expressing the non-neuronal form of human TrkA (Hempstead et al., 
1992; Llovera et al., 2004) were treated with Nerve Growth Factor (NGF). TrkA and ß-
catenin co-immunoprecipitated from PC12 6/15 lysates independently of NGF 
stimulation (Fig. 1A). To investigate whether this association extended to other Trk 
receptors we used hippocampal neurons, which express TrkB and TrkC (Martinez et al., 
1998). Using anti-pan Trk antibodies we immunoprecipitated TrkB and TrkC from 
untreated and BDNF or NT-3-treated neurons. ß-catenin co-immunoprecipitated with 
TrkB and TrkC from hippocampal neuron lysates (Fig. 1B). Thus, ß-catenin interacts 
with Trk receptors in PC12 cells and developing neurons.  
 
Trk phosphorylates ß-catenin at Y654  
The interaction of Trk receptors with ß-catenin raises the possibility that ß-catenin could 
be phosphorylated by these RTK. In in vitro phosphorylation assays, recombinant TrkA 
kinase or TrkA immunoprecipitated from PC12 6/15 cells was incubated with 
recombinant wild-type (WT) or mutant ß-catenin in the presence or absence of the Trk 
kinase inhibitor, K252a. Following the addition of ATP, TrkA kinase produced a robust 
tyrosine phosphorylation of WT GST-ß-catenin (Fig.2A). Preincubation of TrkA kinase 
with K252a reduced TrkA kinase activation to basal levels and blocked GST-ß-catenin 
phosphorylation (Fig. 2A). Interestingly, phosphorylation of mutant Y654F GST-ß-
catenin by TrkA kinase was ~ 45% lower than that of WT GST-ß-catenin, while Y142F 
GST-ß-catenin phosphorylation was ~ 15% lower than phosphorylation of the WT 
protein (Fig.2A). TrkA immunoprecipitated from PC12 cells also induced  ß-catenin 
tyrosine phosphorylation upon addition of ATP that was decreased by 30% by K252a 
(Fig. 2B). Furthermore, Y654F ß-catenin phosphorylation was significantly lower (~ 
40%) than that of WT ß-catenin while the residual phosphorylation of Y654F ß-catenin 
was not inhibited by K252a (Fig. 2B). Together, kinase assays indicate that TrkA 
phosphorylates ß-catenin in vitro at Y654. 
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To study further the role of Trk in ß-catenin phosphorylation, ß-catenin 
immunoprecipitation was performed on lysates from 6/15 PC12 cells and hippocampal 
neurons in the presence or absence of pervanadate (to inhibit tyrosine phosphatases) for 
subsequent Western blot analysis using phosphospecific antibodies. Phosphorylated-
Y654 (P-Y654) ß-catenin was detected in both  PC12 and hippocampal cell lysates and 
levels of  P-Y654 ß-catenin increased following NGF, BDNF and NT-3 stimulation of 
PC12 cells and hippocampal neurons respectively, correlating with Trk phosphorylation 
(Fig. 2C, D). Stimulation with BDNF (50 ng/ml) for 10 minutes induced the 
phosphorylation of Y654, which peaks at 1 hour and was reduced after overnight 
treatment (Fig. 2E, F). In contrast, phosphorylation of Y142 was maintained at basal 
levels (Fig. 2E), indicating that NT signalling specifically phosphorylates ß-catenin 
Y654. In addition to TrkB N-cadherin also co-immunoprecipitated with ß-catenin (Fig. 
2E), suggesting that ß-catenin, N-cadherin and Trk interact in a big complex. Altogether 
these findings demonstrate that Trk receptors phosphorylate ß-catenin Y654 in PC12 
cells and in primary neurons.      
 
Met interacts with ß-catenin and phosphorylates ß-catenin Y142 
HGF and Met, its RTK are both expressed in the hippocampus (Honda et al., 1995; 
Korhonen et al., 2000). This localization led us to examine whether Met, like Trk, 
interacts with and phosphorylates ß-catenin. We found that Met and ß-catenin co-
immunoprecipitate from hippocampal neuron lysates and that this association decreases 
upon HGF treatment with or without pervanadate by 87.6 ± 3.3% and 85.6 ± 5.1%, 
compared to control (n≥3) (Fig. 3B). This interaction suggested that ß-catenin may be 
phosphorylated by Met. Using antibodies specific for P-Y142,  recombinant  Met kinase 
was found to induce the phosphorylation of WT GST-ß-catenin at Y142 upon addition 
of ATP. This decreased to basal levels when using mutant Y142F GST-ß-catenin (Fig. 
3A). In contrast, phosphorylation of Y654F GST-ß-catenin was similar to that of the 
WT protein. Furthermore, prior treatment with HGF (50 ng/ml, 10 minutes) with or 
without pervanadate induced the phosphorylation of ß-catenin Y142 in ß-catenin 
immunoprecipitates isolated from hippocampal neurons (Fig. 3B). Following a peak 
phosphorylation at 10 minutes, P-Y142 was maintained up to 1 hour and started to 
decay slightly after overnight stimulation with HGF (Fig. 3C). Contrary to BDNF and 
NT-3 signaling, Y654 phosphorylation was not stimulated by HGF treatments (Fig. 3B) 
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indicating that NT and HGF signalling phosphorylate different tyrosine residues.  
Interestingly, α-catenin (Fig. 3B) and N-cadherin (data not shown) co-
immunoprecipitated with ß-catenin and the phosphorylation of ß-catenin at Y142 
resulted in decreased amounts of α-catenin in the ß-catenin immunoprecipitates (88 ± 
5% and 77 ± 3.4 % lower in HGF and HGF+pervanadate than in control; n≥3;  Fig. 3B). 
Together these findings indicate that Met interacts with ß-catenin engaged in the 
adhesion complex and phosphorylates Y142, resulting in the detachment of α-catenin 
from ß-catenin.  
 
ß-catenin is involved in axon growth in hippocampal neurons 
Next we investigated the possible role of ß-catenin and its interactions with Trk and Met 
in axon growth because both types of molecules have been implicated in axon 
morphogenesis (Honda et al., 1995; Huang and Reichardt, 2001; Huang and Reichardt, 
2003; Riehl et al., 1996). First, we analyzed the involvement of ß-catenin in axon 
growth in the absence of neurotrophic factor signalling. In order to do this we designed 
scrambled and ß-catenin shRNA vectors for lentiviral infection of hippocampal neurons. 
Quantification of  Western blots of neurons expressing ß-catenin shRNA#1 and #2 
indicate a decrease of  ß-catenin total levels of about 25 and 20% at three days of 
infection compared to neurons expressing scrambled shRNA (Fig. 4A). Anti-ß-catenin 
immunostaining indicates reduced ß-catenin immunoreactivity, especially along the 
axon of GFP-positive neurons expressing ß-catenin shRNA#1 (Fig. 4A). We measured 
axon length in neurons expressing scrambled or ß-catenin shRNAs. In these 
experiments axon length was measured at 3 days in vitro (DIV) because this was the 
earliest time point at which we observed a significant reduction in the levels of ß-
catenin and axon length was still easily measured. Neurons expressing ß-catenin 
shRNAs exhibit significantly shorter axons than neurons expressing scrambled shRNA 
(Fig. 4B, C). Furthermore, stimulation of TrkB and Met by BDNF and HGF 
respectively, increases axon length in neurons expressing scrambled shRNA (Fig. 4C). 
However, in neurons expressing ß-catenin shRNA#1 and #2, BDNF or HGF treatment 
can not stimulate axon growth (Fig. 4C). These results demonstrate that ß-catenin is 
required for axon growth downstream of BDNF and HGF signalling.  
 
To further test the requirement of ß-catenin in axon growth, we also expressed the 
intracellular domain of N-cadherin, which was previously used to study dendritogenesis 
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(Yu and Malenka, 2003). Intracellular N-cadherin sequesters ß-catenin, inhibiting its 
degradation and transactivation capacity (Sadot et al., 1998). For these experiments 
neurons were co-transfected with EYFP and ß-catenin or intracellular N-cadherin (1:4 
ratio) (Yu and Malenka, 2003) and stimulated with either BDNF or HGF before axon 
length was measured. BDNF and HGF promoted axon growth in neurons expressing ß-
catenin (see below) but these effects were inhibited in neurons that express intracellular 
N-cadherin (Fig. 4D). Together with our results on ß-catenin knockdown, these findings 
demonstrate that decreasing the availability of ß-catenin inhibits the axon growth 
induced by BDNF and HGF signalling.   
 
NTs regulate axon growth and branching by phosphorylating ß-catenin Y654 
We then looked at  the physiological consequences of ß-catenin phosphorylation by Trk, 
by studying axon growth induced by NTs in neurons co-expressing WT or mutant ß-
catenin and EYFP. Neurons expressing EYFP alone or together with ß-catenin did not 
show axon length values that were significantly different (data not shown). Neurons 
were treated with BDNF, NT-3 or both and axon length was measured at 2 DIV. 
Stimulation with BDNF, NT-3 or both increased axon length in neurons expressing 
EYFP alone by 31%, 18% and 39% respectively (Fig. 5A, B). Neurons overexpressing 
ß-catenin treated with BDNF, NT-3 or both exhibited axons 44%, 20%, and 29% longer 
respectively than untreated neurons (Fig. 5A, B). Thus, NT treatment increases axon 
growth in a similar manner in neurons overexpressing or not ß-catenin. BDNF together 
with NT-3 did not increase axon length significantly more than BDNF or NT-3 alone, 
suggesting that signalling by only one NT was already maximal. Neurons expressing ß-
catenin treated with BDNF together with the pharmacological inhibitor of Trk activity 
K252a displayed axons with a length similar to that of controls (Fig. 5A, B). We found 
that in addition to increasing axon length, BDNF and NT-3 also increased axonal 
branching (measured as Total Axonal Branch Tip Number, TABTN) by a 35% and 37% 
respectively compared to control neurons. Furthermore, addition of K252a together with 
BDNF reduced branching to values similar to the control (Fig. 5A, C). K252a has 
recently been reported to inhibit Met (Morotti et al., 2002) as well as Trk. However, as 
BDNF binds to TrkB and K252a inhibited the effects of BDNF, our results strongly 
suggest that Trk receptors mediate the BDNF effects in axon growth and branching. 
 
 10
We also examined the role of ß-catenin phosphorylation at Y654 in axon growth and 
branching, using mutant Y654F ß-catenin which is not phosphorylable at Y654. 
Untreated neurons expressing Y654F ß-catenin exhibited axons of similar length to 
those of neurons expressing WT ß-catenin (data not shown). Interestingly, we found 
that neurons expressing Y654F ß-catenin treated with BDNF or NT-3 exhibited axon 
lengths similar to those of untreated neurons (Fig. 5A, B). We therefore concluded that 
expression of Y654F mutant blocks the NT-induced stimulation of axon growth. 
Expressing Y654F ß-catenin also abolished the NT-induced axon branching (Fig. 5A, 
C). Conversely, expression of the Y142F ß-catenin mutant did not affect the length or 
branching of the axon induced by NTs (Fig. 5). Altogether, these results demonstrate 
that phosphorylation at ß-catenin Y654 (and not at Y142) is required for the axon 
extension and branching promoted by NTs. 
 
HGF regulates axon growth and branching by phosphorylating ß-catenin Y142  
Treatment with HGF also increased axon growth of hippocampal neurons expressing 
EYFP (18 %) or EYFP and WT ß-catenin (35 % compared to untreated neurons; Fig. 
6A, B). Remarkably, neurons expressing Y142F ß-catenin showed no increase in axon 
length compared to control cells upon HGF treatment (Fig. 6A, B). In contrast, neurons 
expressing Y654F ß-catenin treated with HGF exhibited axons longer than untreated 
neurons (41% compared to control; Fig. 6A, B). Treatment with BDNF and HGF did 
not increase axon length further than BDNF or HGF alone (data not shown). Moreover, 
HGF signalling increased axon branching in neurons expressing EYFP, EYFP and WT 
ß-catenin or EYFP and Y654F ß-catenin (Fig. 6A, C). However, the axon branching 
induced by HGF was blocked when expressing Y142F ß-catenin. These results 
demonstrate that phosphorylation of Y142 is required for the regulation of axon growth 
and branching induced by HGF. Dendrite length and branching of EYFP-expressing 
neurons was not stimulated by BDNF or HGF treatments at 2 DIV suggesting that 
dendrite morphogenesis is not regulated by tyrosine phosphorylation of  ß-catenin at 
this stage of the hippocampal neuron development (Table 1). In summary, our data 
indicates that ß-catenin is specifically phosphorylated at two different sites, Y654 and 
Y142, by NTs and HGF signalling to regulate axon growth and branching. 
 
P-Y654 ß-catenin colocalizes with the neuronal cytoskeleton, whereas P-Y142 is 
found in the nucleus  
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To begin to elucidate the downstream events resulting from ß-catenin tyrosine 
phosphorylation at Y654 and Y142 sites, we examined the subcellular localization of 
the phosphorylated forms, P-Y654 and P-Y142 in hippocampal neurons. ß-catenin P-
Y654 is present in the cytoplasm, along the axon and at neurite tips and growth cones, 
where it colocalizes with actin and ßIII-tubulin (Fig. 7A-C). In contrast, ß-catenin P-
Y142 localizes to the cytoplasm and nucleus of neurons (Fig. 7D). Anti-Met and anti-ß-
catenin immunostainings also colocalize along neurites, at tips and in the cytoplasm 
(Suppl. Fig. 1). However, anti-Met and Hoestch staining do not significantly colocalize 
(Supp. Fig. 1), suggesting that Met does not translocate to the nucleus to maintain Y142 
phosphorylation. Thus, phosphorylation at Y654 and Y142 targets ß-catenin to different 
subcellular compartments, suggesting that these two phosphorylated forms of ß-catenin 
may involve distinct mechanisms to regulate axon morphogenesis. 
 
Dominant negative ∆N-TCF4 blocks the effect of HGF in axon growth 
In canonical Wnt signalling, nuclear ß-catenin binds to the promoter of TCF/LEF to 
regulate gene transcription (Logan and Nusse, 2004). Consequently TCF factors are 
likely candidates in the response activated by nuclear ß-catenin. Since P-Y142 ß-catenin 
was observed in the nucleus, we investigated whether dominant negative ∆N-TCF4 that 
can not bind ß-catenin (Roose et al., 1999) was able to modify the NT or HGF effects 
on axon growth and branching. As a positive control, we treated ∆N-TCF4 expressing 
hippocampal neurons with Wnt-3a, which signals through the canonical Wnt pathway in 
dorsal root ganglia neurite outgrowth (Lu et al., 2004). Wnt-3a-treated neurons 
overexpressing EYFP alone or together with WT ß-catenin exhibited axons 47 % or 
46% longer than controls. Expression of ∆N-TCF4 abolished the stimulation of axon 
growth induced by Wnt-3a (Fig. 8B), indicating that ∆N-TCF4 blocks ß-catenin nuclear 
signalling and that in hippocampal neurons Wnt-3a acts through the canonical pathway 
to increase axon growth. Interestingly, the HGF-induced axon growth and branching 
was also prevented in neurons expressing ∆N-TCF4, whereas the BDNF and NT-3 
effects were not altered (Fig. 8). These results indicate that HGF signals through TCF4 
in axon growth and branching. In summary, our results indicate that HGF signalling 
phosphorylates ß-catenin at Y142, inducing its nuclear translocation and TCF4-
mediated gene transcription to regulate axon morphogenesis. In contrast, NT signalling 
promotes axon growth and branching by phosphorylating ß-catenin Y654 independent 
of TCF4 function.
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Discussion 
Brain function relies on the establishment of the correct pattern of neuronal connections. 
During development neurons extend their axons under the influence of many signalling 
molecules (Ayala et al., 2007; Ciani and Salinas, 2005; Dalva et al., 2007; Huang and 
Reichardt, 2001) that results in the unique morphology of axon arbors and the formation 
of synapses. ß-catenin is a component of the cell adhesion complex and the canonical 
Wnt pathway that plays a prominent role in development, synapse formation and 
disease (Ciani and Salinas, 2005; Clevers, 2006; Goda, 2002; Logan and Nusse, 2004; 
Moon et al., 2004; Salinas and Price, 2005). In neurons, ß-catenin tyrosine 
phosphorylation regulates synapse formation and function (Bamji et al., 2006; Murase 
et al., 2002). Here we have shown that differential ß-catenin tyrosine phosphorylation 
by growth factor (NTs and HGF) signalling regulates axon morphogenesis. First, by 
expressing lentiviral-driven ß-catenin shRNAs or sequestering ß-catenin with 
intracellular N-cadherin, we demonstrate the requirement for ß-catenin in axon 
outgrowth downstream of growth factor signalling. Second, we show that neuronal RTK 
Trk and Met phosphorylate ß-catenin. We have identified Y654 and Y142 as the sites 
phosphorylated upon NT and HGF stimulation, respectively. We have also 
demonstrated the key role that Y654 and Y142 phosphorylations play in the regulation 
of axon growth and branching elicited by either family of growth factors. Our data 
indicates that although NT and HGF signalling converge on ß-catenin, the pathways that 
control the growth and arborization of the axon diverge downstream of ß-catenin Y654 
and Y142 phosphorylations. The NT-phosphorylated form P-Y654 ß-catenin is found at 
growth cones, whereas P-Y142 ß-catenin translocates to the nucleus. Furthermore, the 
transcription factor TCF4, a central player of canonical Wnt signalling, is needed for 
HGF but not for NT signalling during axon growth and branching. Therefore, 
components of the Wnt pathway are shared by the signalling cascades activated by 
growth factors during axon morphogenesis. We have concluded that HGF and NTs, by 
activating their RTK, phosphorylate ß-catenin at different sites, thus involving 
transcription-dependent and independent mechanisms that result in the fine tuning of 
axon morphogenesis.   
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In this paper we have presented evidence for the interaction of ß-catenin with Trk and 
Met and demonstrate for the first time the involvement of ß-catenin phosphorylation 
downstream of both RTK in the regulation of axon growth and branching. Previous 
studies illustrated the relationship between ß-catenin phosphorylation and RTK such as 
EGFR, Met and PDGF receptor in epithelial and tumoral cell migration (Brembeck et 
al., 2004; Hiscox and Jiang, 1999; Hoschuetzky et al., 1994; Theisen et al., 2007). We 
have shown that ß-catenin is associated with TrkA, TrkB and TrkC in PC12 cells and 
hippocampal neurons. The interaction of ß-catenin with Trk was independent of ligand 
stimulation, as described for EGFR (Hoschuetzky et al., 1994). In addition, ß-catenin is 
a direct substrate of TrkA kinase in vitro. Substitution of Y654 by a phenylalanine 
results in a significant reduction of ß-catenin phosphorylation by TrkA, whereas an 
Y142F mutation affected ß-catenin phosphorylation to a much lesser extent. These 
experiments demonstrate that TrkA phosphorylates Y654 in vitro. Using TrkA 
immunoprecipitated from PC12 cells, the residual tyrosine phosphorylation of Y654F ß-
catenin was not prevented by a Trk inhibitor. TrkB was reported to associate with the 
non-receptor tyrosine kinase Fyn (Iwasaki et al., 1998; Pereira and Chao, 2007), which 
phosphorylates ß-catenin at Y142 (Piedra et al., 2003). Our results also suggest that 
TrkA or a kinase that co-immunoprecipitates with TrkA, possibly Fyn, phosphorylates 
Y654F ß-catenin in vitro. More importantly, ß-catenin is phosphorylated at Y654 
following activation of all three Trk receptors in PC12 cells and primary neurons. 
Phosphorylation of Y142 was not induced by BDNF, suggesting that NT signalling 
specifically targets ß-catenin Y654 in a cellular context. Moreover, we have shown that 
ß-catenin also associates with neuronal Met. ß-catenin was phosphorylated by Met at 
Y142 in vitro and in neurons following HGF stimulation. In contrast, phosphorylation 
of mutant Y654F was similar to that of WT ß-catenin and HGF treatment did not 
stimulate phosphorylation of Y654 in neurons, indicating a selectivity of HGF/Met 
signalling for Y142. Finally, we observed a decreased association of Met and ß-catenin 
upon Y142 phosphorylation. Together, these findings extend to a neuronal context our 
knowledge about HGF signalling in non-neural cells (Brembeck et al., 2004; Monga et 
al., 2002; Rasola et al., 2007).    
 
BDNF, NT-3 and HGF all induce axon growth and branching in hippocampal neurons 
(Korhonen et al., 2000; Labelle and Leclerc, 2000; Vicario-Abejon et al., 1998). By 
expressing ß-catenin single point mutants, we demonstrate that phosphorylation of ß-
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catenin Y654 is required for the regulation of axon growth and branching induced by 
BDNF or NT-3. Conversely, phosphorylation of ß-catenin Y142 is required for HGF 
signalling in axon morphogenesis. BDNF and HGF effects on axon growth were not 
additive, suggesting maximal signalling by each growth factor alone. Our results 
demonstrate that different growth factors target ß-catenin to partially stimulate the 
growth and arborization of the axon, thus contributing to the complex network of 
pathways that direct this process. In agreement with this conclusion, regulating the 
availability of ß-catenin by either shRNA-mediated ß-catenin silencing or by 
sequestering it by expressing intracellular N-cadherin (Yu and Malenka, 2003) affected 
axon growth both in the presence and absence of exogenous growth factors. The ability 
of intracellular N-cadherin to block ß-catenin transactivation (Sadot et al., 1998) and to 
place ß-catenin away from the RTK could explain the inhibition of the axon growth 
promoted by BDNF and HGF. Together, these results indicate that ß-catenin is required 
for axon growth downstream of growth factor signalling. Dendritic morphogenesis was 
not stimulated by BDNF or HGF signalling, suggesting that it is not regulated by 
tyrosine phosphorylation of  ß-catenin at the initial stages of the hippocampal neuron 
development analyzed. These results do not rule out a possible role of ß-catenin 
phosphorylation on the maturation of the dendritic tree, in agreement with the 
implication of ß-catenin in this later process (Yu and Malenka, 2003). 
 
What are the mechanisms by which NT and HGF signalling regulate axon extension and 
branching? Tyrosine phosphorylation of ß-catenin was proposed to regulate cell 
migration and gene transcription by detaching ß-catenin from the cadherin-catenins 
complex  (Huber and Weis, 2001; Lilien and Balsamo, 2005; Nelson and Nusse, 2004; 
Roura et al., 1999). In keeping with this motion, Bamji et al. (2006) showed that 
tyrosine phosphorylation of ß-catenin upon BDNF treatment reduces ß-catenin affinity 
for N-cadherin and mobilizes synaptic vesicles during synapse formation. Likewise, 
Murase et al. (2002) reported that depolarization, which mimics the effect of a tyrosine 
kinase inhibitor on ß-catenin redistribution to dendritic spines, increases ß-catenin and 
cadherin association in mature hippocampal cultures. In contrast, we were able to 
observe the ß-catenin detachment from N-cadherin in our younger neurons only using 
pervanadate (Ozawa and Kemler, 1998) (Fig. 2E and data not shown). This result 
indicates that it is necessary to inhibit tyrosine phosphatases, which are working in 
consonance with tyrosine kinases (Balsamo et al., 1998; Kypta et al., 1996; Nelson and 
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Nusse, 2004), to detect the detachment of ß-catenin from N-cadherin in 2 DIV 
hippocampal neurons. This result also suggests that a phosphatase that is 
developmentally regulated may dephosphorylate Y654 ß-catenin. In addition, ß-catenin 
and cadherins change their location before and after synapse formation, showing a 
synaptic distribution as neurons mature (Bamji et al., 2006; Bamji et al., 2003; Benson 
and Tanaka, 1998; Uchida et al., 1996). Thus, the dynamic localization of cadherin-
catenin complexes may result in the immunoprecipitation of adhesion complexes 
predominantly assembled at “local pools” (i.e., synapses) in older neurons, where the 
phosphorylation and detachment of ß-catenin could mainly take place. 
 
P-Y654 and P-Y142 ß-catenin were found in different subcellular locations in 
hippocampal neurons. P-Y654 ß-catenin is present at neurite tips and growth cones 
where it colocalizes with cytoskeletal components. This observation suggests that NTs 
by phosphorylating Y654 ß-catenin stimulate axon growth and branching by locally 
regulating the cytoskeleton. Guidance cues regulate growth cone motility and behaviour 
by eliciting local synthesis of proteins (Piper and Holt, 2004) and extensively affecting 
the actin and microtubule cytoskeleton (Kalil and Dent, 2005). While pathways 
activated by NTs may involve signalling to the nucleus (Chao, 2003; Huang and 
Reichardt, 2001; Sole et al., 2004), NTs can also transduce their signals locally and 
affect the cytoskeleton to regulate motility, the neuronal morphology and axon growth 
(Chen et al., 2006; Gehler et al., 2004; Miyamoto et al., 2006; Ye et al., 2003; Zhou et 
al., 2004). NGF induces growth of dorsal root ganglia neuron axons through 
inactivation of GSK-3ß and regulation of the microtubule plus end binding protein APC 
at neurite tips (Arevalo and Chao, 2005; Zhou et al., 2004). BDNF increases filopodial 
length and number, a structure considered the first step in the formation of axonal 
branches (Gallo and Letourneau, 2004), by activating Actin Depolymerazing Factor 
/Cofilin (Chen et al., 2006; Gehler et al., 2004) and decreasing RhoA signalling 
(Yamashita et al., 1999). Indeed, members of the Rho family of small GTPases are key 
regulators of neuronal morphogenesis (Govek et al., 2005; Luo, 2000). Furthermore, the 
HGF- or BDNF-induced motile phenotypes and neurite outgrowth are mediated by Rho 
GTPases (Bosse et al., 2007; Pante et al., 2005; Royal et al., 2000; Zhou et al., 2007). 
Constitutive active RhoA reduces dendrite branching, suggesting that interactions with 
the actin cytoskeleton are critical for the ß-catenin effects in dendritic morphogenesis 
(Yu and Malenka, 2003). Future work should help to clarify the mechanisms mediating 
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ß-catenin phosphorylation and the growth cone in response to NTs in axon 
morphogenesis.    
 
Phosphorylated Y142 ß-catenin was reported to decrease the interaction of α-catenin-ß-
catenin  and to increase the interaction with BCL9-2/Legless allowing its nuclear 
translocation and transcription of ß-catenin target genes (Brembeck et al., 2004). We 
found that in neurons α-catenin-ß-catenin dissociate in response to the HGF-induced ß-
catenin phosphorylation at Y142. The α-catenin-ß-catenin dissociation was observed on 
ß-catenin immunocomplexes also containing Met, thus suggesting that the RTK 
interacts with and phosphorylates a pool of ß-catenin bound to the adhesion complex. P-
Y142 ß-catenin, contrary to P-Y654, was observed in the nucleus in neurons. Consistent 
with this finding, we have shown that the HGF-induced axon growth and branching 
requires TCF4-transcriptional activation. This dependence on TCF4 function is also 
shared by Wnt-3a signalling in axon growth and for the Robo-Abl-Cables-N-cadherin-
ß-catenin regulation of axon guidance mediated by ß-catenin Y489 phosphorylation 
(Rhee et al., 2007). In contrast, the activity-induced dendritic arborization does not 
require TCF-transcriptional activation but rather availability of the cadherin-catenin 
complex (Yu and Malenka, 2003). On the other hand, phosphorylation of Y654 
stimulates the association of ß-catenin to the basal transcription factor TATA-binding 
protein and increases TCF4-mediated transcription in non-neural cell lines (Hecht et al., 
1999; Piedra et al., 2001). Furthermore, it has been suggested that Bcr-Abl 
phosphorylation of ß-catenin Y86 and/or Y654 regulates nuclear ß-catenin signalling in 
chronic myeloid leukemia (Coluccia et al., 2007). Our results in developing neurons 
however indicate that NTs modulate axon growth and branching by phosphorylating ß-
catenin Y654 independently of TCF4 function, possibly by affecting the cytoskeleton.  
 
Because ß-catenin null mice die during early development, the function of ß-catenin in 
the embryonic period has not been tested in vivo. Using conditional knock-out animals, 
a role of ß-catenin on dendrite development of postnatally born hippocampal dentate 
gyrus neurons was identified (Gao et al., 2007). ß-catenin conditional knock-out 
animals also showed a mild phenotype in mood- and anxiety-related behavioral models 
(Gould et al., 2008). However axon morphogenesis of hippocampal neurons has not 
been analyzed during the embryonic development of these animals. Expression of ß-
catenin deletion mutants in retinal ganglion cells of live Xenopus tadpoles (Elul et al., 
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2003) resulted in altered axonal arborization, suggesting that interactions with the N- 
and C-terminal domains of ß-catenin (containing either Y142 or Y654) are required to 
shape these axons in vivo. Investigating the impact of ß-catenin phosphorylation in axon 
morphogenesis during mouse development will require the generation of  Y654F and 
Y142F knock-in mice.  
 
Our results place ß-catenin at a convergence point of both NT/Trk and HGF/Met 
signalling pathways in the regulation of axon growth and branching. Thus our findings 
illustrate the complex networks operating in axon morphogenesis, as stimulation of 
different RTK results in the activation of TCF4 transcription-dependent and 
independent mechanisms downstream of ß-catenin (Fig. 9). It would be interesting to 
investigate which are the TCF4 target genes responsible for the axon growth and 
branching promoted by HGF. In summary, this work highlights the important role 
played by ß-catenin in integrating trophic signals that emanate from RTK during axon 
morphogenesis.   
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Materials and Methods 
Materials 
BDNF and NT-3 were obtained from Alomone Labs, NGF from Sigma, HGF and 
K252a from Calbiochem and Wnt-3a from R&D. Antibodies were purchased from the 
following companies: Met from Santa Cruz, P-Y654 and P-Y142 from Abcam, ßIII-
tubulin from Covance, P-Tyrosine (P-Tyr; 4G10), TrkB and TrkC from Upstate 
Biotechnology, ß-actin from Sigma, ß-catenin from BD Transduction Laboratories, N-
cadherin from Zymed, α-catenin from the Hybridoma Bank and EYFP/GFP from Acris 
Antibodies.  
 
TrkA immunoprecipitation and in vitro kinase assays 
TrkA was isolated from a PC12 clone overexpressing human TrkA (PC12 6/15) 
following stimulation with NGF 100 ng/ml (7 minutes at 37˚C). Cells were lysed in 
RIPA buffer (50 mM Tris-HCl, pH 7,5, 150 mM NaCl, 5 mM EDTA pH 8, 1% NP-40, 
0.5% sodium deoxycholate, 0.1% SDS, 5mM DTT) containing Complete protease 
inhibitor (Roche), 40 mM ß-glycerophosphate, 1mM sodium ortovanadate and 25 mM 
sodium fluoride. Cell lysates were incubated with anti-pan Trk antibodies (Martin-
Zanca et al.,1989) followed by Protein G-Sepharose (Sigma). GST-ß-catenin 
recombinant proteins (Roura et al., 1999) were produced in BL21 bacteria and cleaved 
from GST with thrombin where necessary (8U to cleave 1 mg protein, 80 minutes, 
30˚C). GST-ß-catenin (0.8 µg; 6.7 pmols) phosphorylation by recombinant TrkA and 
Met kinases (Cell Signalling) was performed following manufacturer’s instructions (15 
minutes, 30˚C). ß-catenin (1.5 µg; 17 pmols) phosphorylation by immunoprecipitated 
TrkA was assayed (20 minutes, 30˚C) in kinase buffer (50 mM Hepes, pH 7,4, 10 mM 
MgCl2, 5 mM MnCl2, 0.5 mM EDTA, 1mM DTT, 0.1% NP-40, 1 mM sodium 
ortovanadate with or without 100 nM K252a (preincubated with the kinase 5 minutes, 
RT) and 0.1 mM ATP. Samples were analyzed by Western blot.   
   
Hippocampal cultures and transfection 
Rat primary hippocampal neurons were isolated from 18-19 day embryos and cultured 
in DMEM medium supplemented with N2 and B27. Neurons were plated on poly-D-
lysine coated glass coverslips either at 500-1000 cells/mm2 for transfection or 
biochemical experiments or 70 cells/mm2 for immunostaining following lentiviral 
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infection. WT, Y654F and Y142F ß-catenin cDNAs were obtained and cloned into 
pcDNA3.1 as described (Piedra et al., 2003). Xenopus intracellular N-cadherin 
(containing part of the fifth extracellular domain, the transmembrane and the 
cytoplasmic domains) was kindly provided by Dr. X. Yu (Yu and Malenka, 2003). Cells 
were co-transfected at 1 day in vitro (DIV) with 1.2 µg of ß-catenin/cadherin constructs 
and 0.3 µg of EYFP DNA using Lipofectamine 2000 (Invitrogen) (Espinet et al., 2000). 
After 3 hours the medium was changed and supplemented with appropiate growth 
factors, Wnt-3a (all at 50 ng/ml) and K252a (100 nM; preincubated 20 minutes before 
BDNF addition) when necessary. Neurons were fixed at 2 DIV and immunostained with 
anti-GFP antibodies.  
 
Immunofluorescence and measurements 
For phosphospecific ß-catenin immunostaining neurons were treated with pervanadate 
(1 mM, 15 minutes, 37˚C) before fixation. Neurons were fixed with 4 % 
paraformaldehyde (PFA) for 20 minutes at RT. For cytoskeletal staining detergent 
fixation (3% formaldehyde, 0.2% glutaraldehyde, 0.2% Triton X100, 10 mM EGTA pH 
7.2) was used (10 minutes, 37˚C) where indicated. Binding of TRITC or FITC-
Phalloidin (0.2 µg/ml in PBS, 1 hour at RT; Sigma) to localize actin filaments was 
performed in cells permeabilized with 0.2% Triton X100 in PBS without blocking. 
Cells were washed with phosphate buffer saline (PBS) and blocked and permeabilized 
in PBS containing 5% Foetal calf serum , 5% Horse serum, 0.2% glycine and 0.1% 
Triton X100. Secondary antibodies were Alexa Fluor 488 and Fluor 594 (Molecular 
Probes). Micrographs were obtained using an inverted Olympus IX70 microscope (10x, 
0.3 NA and 20x, 0.4 NA) equipped with epifluorescence optics and a camera (Olympus 
OM-4 Ti). Images were acquired using DPM Manager Software. Alternatively, images 
were obtained using an Olympus confocal IX70 microscope and the FluoView 500 
Software  and processed using MacBiophotonics ImageJ software 
(www.macbiophotonics.ca). Axon length was measured using Adobe Photoshop 
software and the axon was identified as the longest neurite at this stage (2 DIV) of the 
hippocampal cell development. Branching was measured by counting Total Axonal 
Branch Tip Number (TABTN)(Yu and Malenka, 2004). Typically, 15-20 neurons were 
measured/condition in ≥ three independent experiments. Axon length and branching 
plots represent values normalized to the corresponding untreated control, shown as 
average ± s.e.m. Significance was calculated by the Student T test. Asterisk (*) 
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indicates statistical significance compared to  the corresponding untreated control and 
hash (#) compared to stimulated controls (see legends for details). 
 
Immunoprecipitations and Western blotting 
Neurons were deprived of B27 overnight and stimulated with growth factors (50 ng/ml, 
10 minutes, unless otherwise indicated) at 2 DIV. Cells were treated with pervanadate to 
inhibit tyrosine phosphatases (1mM final; 10 minutes together with the stimulus) where 
indicated.  6/15 PC12 cells were serum starved overnight before stimulation with NGF 
100 ng/ml. PC12 cells and hippocampal neurons were lysed in NP-40 (20 mM Tris-
HCl, pH 7,4, 140 mM NaCl, 10% glycerol and 1% NP-40) or RIPA buffer containing 
protease and phosphate inhibitors. RIPA buffer was used for all the experiments 
showing ß-catenin phosphorylation in neurons. Cell lysates were incubated with 
antibodies and Protein-G-Sepharose overnight at 4˚C prior to Western blot analysis.  
Densitometric analysis of the scanned film images was performed using Scion software. 
ß-catenin phosphorylation was calculated by referring the intensity of the 
phosphospecific band to that of the untreated control and normalizing against total ß-
catenin (see legends).    
 
ShRNA by lentiviral infection 
shRNA primers specific for rat ß-catenin were designed chosen using algorithms 
available on Promega and Invitrogen websites. The primers selected correspond to 
GTTTGTGCAGTTGCTTTAT (shRNA#1) and GGGTTCCGATGATATAAAT 
(shRNA#2). Primers were designed for cloning into pSUPER plasmid using the BglII 
and HindIII sites. They were subcloned into the pLVTHM plasmid (from Dr. Trono, 
Geneva) together with the H1 promoter for the RNA pol III. shRNA vectors were 
transfected into HEK293T cells together with the plasmids psPAX2 and pMD2G (from 
Dr Trono) using the polyethyleneimine transfection method. Transfection efficiency 
was analyzed by GFP expression (driven by the pLVTHM plasmid). The HEK293T 
medium was collected after 48 hours of transfection and centrifuged at 50,000xg for 3 
hours. The viral pellet was resuspended in sterile PBS plus 2% Bovine Serum Albumin. 
Hippocampal neurons were transduced 2 hours after plating. According to GFP 
expression driven by the lentiviral vector ~ 90-95% of neurons were transduced.  
Neurons were stimulated with growth factors at 2 DIV and fixed at 3 DIV for GFP 
immunostaining and measurement of axon length with at least 25 or more GFP-positive 
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transduced neurons measured/condition. 
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Figure legends 
Figure 1. ß-catenin interacts with TrkA in PC12 cells and with TrkB and TrkC in 
hippocampal neurons. (A) Control (Myc) or ß-catenin immunoprecipitation from 6/15 
PC12 cells starved or stimulated with NGF (100 ng/ml) for different times shows that 
TrkA (detected with panTrk antibodies: 140 kDa and 110 kDa forms) co-
immunoprecipitates with ß-catenin, independent of its phosphorylation state. (B) 
Control (GFP) or pan-Trk immunoprecipitation from hippocampal neurons untreated or 
treated with BDNF or NT-3 (50 ng/ml; 5 minutes) shows that TrkB and TrkC co-
immunoprecipitate with ß-catenin.  
 
Figure 2. Trk phosphorylates ß-catenin at Y654. (A) In vitro kinase assay using 
recombinant TrkA kinase and WT or mutant GST-ß-catenin. Anti-P-Tyr Western blot 
shows phosphorylated TrkA kinase and GST-ß-catenin. WT GST-ß-catenin is 
phosphorylated by TrkA kinase upon addition of ATP, while K252a inhibits the TrkA 
induced-ß-catenin phosphorylation. Phosphorylation of Y654F and Y142F GST-ß-
catenin by TrkA kinase is ~ 45% and 15% lower than that of WT GST-ß-catenin. Panel 
below shows anti-ß-catenin Western blot for the GST-ß-catenin input in the kinase 
assay (0.8 µg). (B) In vitro kinase assay using TrkA immunoprecipitated from 6/15 
PC12 and recombinant WT and Y654F ß-catenin. Anti-P-Tyr Western blot shows TrkA 
(140 kDa and 110 kDa bands) and the tyrosine phosphorylation of ß-catenin. 
Phosphorylation of WT ß-catenin is decreased by preincubation with K252a (100 nM), 
whereas phosphorylation of Y654F ß-catenin is lower than that of WT ß-catenin and not 
inhibited by K252a. In the first lane no recombinant ß-catenin was added to control for 
phosphorylation of any endogenous ß-catenin that may have been immunoprecipitated 
with TrkA. Quantification corresponds to % of the increase in the intensity of  P-Tyr ß-
catenin relative to minus ATP/total ß-catenin. (C) Control (Myc) or ß-catenin 
immunoprecipitation from 6/15 PC12 cells untreated or treated with NGF 100 ng/ml 
and pervanadate for the last 10 minutes of stimulation. Phosphorylation of ß-catenin 
Y654 increases after NGF treatment in parallel with TrkA stimulation as detected by 
anti-P-Tyr Western blot. (D) Control (His) or ß-catenin immunoprecipitation from 
untreated hippocampal neurons or those treated for 10 minutes with BDNF or NT-3 50 
ng/ml in the presence of pervanadate. Upon NT stimulation,  phosphorylation of  ß-
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catenin at Y654 increases parallel with phosphorylation of TrkB/C detected by anti-P-
Tyr Western blot. (E) Control or ß-catenin immunoprecipitation from hippocampal 
neurons untreated or treated for 10 minutes with BDNF 50 ng/ml with or without 
pervanadate. ß-catenin P-Y654 increases with BDNF treatments both with and without 
pervanadate, while phosphorylation at Y142 is maintained at basal level increasing only 
slightly with pervanadate. TrkB and N-cadherin co-immunoprecipitate with ß-catenin 
and N-cadherin association shows a small decrease after pervanadate treatment. (F) ß-
catenin immunoprecipitation from untreated neurons or those treated with BDNF 50 
ng/ml for the indicated times in the presence of  pervanadate for the last 10 minutes of 
stimulation. ß-catenin P-Y654 peaks at 1 hour and is reduced after overnight 
stimulation. Quantifications in C, D, E and F correspond to % of the increase in the 
intensity of the phosphospecific ß-catenin (P-Y654 or P-Y142) band relative to the 
control  normalized to total ß-catenin.  
 
Figure 3. Met phosphorylates ß-catenin at Y142. (A) In vitro kinase assay with 
recombinant Met kinase and WT or mutant GST-ß-catenin. Anti-P-Tyr Western blot 
shows phosphorylated Met kinase upon addition of ATP and its basal activation (-ATP 
condition). Anti-P-Y142 Western blot indicates that WT and Y654F GST-ß-catenin are 
phosphorylated by Met kinase at Y142, whereas phosphorylation of Y142F GST-ß-
catenin is as low as in basal condition (-ATP). (B) Control (His) or ß-catenin 
immunoprecipitation from untreated hippocampal neurons or those treated with HGF 50 
ng/ml for 10 minutes with or without pervanadate. ß-catenin P-Y142 increases with 
HGF treatments, whereas phosphorylation at Y654 is not stimulated by HGF signalling. 
Met and α-catenin co-immunoprecipitate with ß-catenin, and the recovery of both 
proteins decreases upon phosphorylation of  ß-catenin at Y142. (C) ß-catenin 
immunoprecipitation from untreated neurons or those treated with HGF 50 ng/ml for the 
indicated times. ß-catenin P-Y142 peaks at 10 minutes, is maintained at similar levels 
up to 1 hour and starts decaying slightly after overnight stimulation. Quantifications in 
B and C correspond to % of the increase in the intensity of the phosphospecific ß-
catenin  band relative to the control normalized to total ß-catenin.  
 
Figure 4. ß-catenin is involved in axon growth downstream of BDNF and HGF 
signalling. (A) Western blot from hippocampal neurons infected with lentiviral-driven 
scrambled or ß-catenin shRNA#1 and #2 shows the decrease in ß-catenin expression by 
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ß-catenin shRNAs compared to scrambled shRNA (scr) or non-infected (ni) neurons. 
Actin was used as a loading control. Plot represents quantification of  ß-catenin 
corrected against the loading control (n ≥ 4 experiments). Panels show confocal images 
for anti-ß-catenin and anti-GFP (indicating transduced neurons) immunostainings in 
neurons expressing scrambled or ß-catenin shRNA#1. Note the lower levels of  ß-
catenin especially along the axon in ß-catenin shRNA#1-expressing neurons. Arrows 
indicate colocalization between GFP and ß-catenin immunostainings in neurons 
expressing scrambled shRNA that is reduced in neurons expressing ß-catenin shRNA#1. 
Bar= 20 µm. (B) Hippocampal neurons expressing scrambled or ß-catenin shRNA#1 
fixed and immunostained against GFP (driven by the lentiviral vector) at 3 DIV show 
the decrease in axon length obtained by expressing shRNA#1. Bar = 40 µm. (C) 
Quantification of axon length of scrambled and ß-catenin shRNA neurons, untreated or 
treated with BDNF or HGF (normalized to untreated neurons expressing scrambled 
shRNA). Neurons expressing ß-catenin shRNA#1 and #2 display axons shorter than 
controls. Stimulation with BDNF or HGF (50 ng/ml) promotes axon growth in neurons 
expressing scrambled shRNA, but not in neurons expressing ß-catenin shRNA#1 and #2 
(n = 4-8 experiments). *p≤0.05, **, p≤0.01, *** p≤0.001 when comparing to the 
untreated neurons expressing scrambled shRNA; #p≤0.05, ## p≤0.01 when comparing 
to the BDNF or HGF-treated neurons expressing scrambled shRNA. (D) Quantification 
of axon length in neurons expressing N-cadherin intracellular or ß-catenin, either 
untreated or stimulated with BDNF or HGF (normalized to the respective untreated 
neurons). Neurons expressing ß-catenin display axons longer than controls upon BDNF 
or HGF (50 ng/ml) stimulation. In contrast, in neurons expressing intracellular N-
cadherin, BDNF or HGF can not stimulate axon growth (n = 4 experiments). *p≤0.05, 
*** p≤0.001 when comparing to the corresponding untreated control; #p≤0.05, ## 
p≤0.01 when comparing to the BDNF or HGF-stimulated ß-catenin-expressing neurons. 
 
Figure 5. ß-catenin phosphorylation at Y654 regulates axon growth and branching 
induced by NTs. (A) Hippocampal neurons transfected with EYFP alone (control) or 
with EYFP and WT or mutant (Y654F or Y142F) ß-catenin. BDNF and NT-3 (50 
ng/ml) induce axon growth and branching in control neurons and in neurons 
overexpressing WT or Y142F ß-catenin, but the NT-induced axon growth is inhibited in 
neurons expressing the mutation Y654F. Treatment with BDNF plus K252a results in 
axons with a length and branching values similar to those of untreated neurons and of  
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Y654F-expressing cells. Bar= 80 µm. (B) Quantification of axon length normalized to 
the respective control. BDNF and NT-3 increase axon length in control EYFP neurons 
and in neurons expressing WT or Y142F ß-catenin, but not in neurons expressing the 
Y654F mutant. Treatment with BDNF together with NT-3  does not result in a 
significant further increase. Treatment with K252a (100 nM) and BDNF abolishes the 
increase in axon length induced by BDNF. (C) Quantification of axon branching 
(TABTN) shows that BDNF and NT-3 increase branching of axons expressing WT and 
Y142F ß-catenin, but expression of Y654F abolishes the branching induced by NTs. 
K252a (100 nM) together with BDNF abolishes the BDNF-promoted branching. 
(*P≤0.05, ** P≤0.01, *** P≤0.001;  n = 3-8 experiments). 
 
Figure 6. ß-catenin phosphorylation at Y142 regulates axon growth induced by 
HGF. (A) Hippocampal neurons transfected with EYFP alone (control) or with EYFP 
and WT or mutant (Y654F or Y142F) ß-catenin. HGF (50 ng/ml) induces axon growth 
in neurons expressing WT or Y654F ß-catenin, but the HGF-induced axon growth is 
inhibited in neurons expressing the mutation Y142F. Bar = 40 µm. (B) Quantification of 
axon length normalized to the respective control shows that HGF increases axon length 
in neurons expressing WT and Y654F ß-catenin, but not in neurons expressing Y142F. 
(C) Quantification of axon branching shows that HGF treatment induces axon branching 
that is blocked by the Y142F mutation (* P≤0.05, ** P≤0.01; n = 4-7 experiments). 
 
Figure 7. P-Y654 ß-catenin colocalizes with the neuronal cytoskeleton and P-Y142 
is found in the nucleus. (A) Double immunostaining for endogenous ß-catenin and F-
actin (phalloidin) in hippocampal neurons shows that ß-catenin and F-actin partially 
colocalize (arrows) at neurite tips and lamella (inset). (B) Confocal image of 
hippocampal neurons fixed using detergent fixation shows the double immunostaining 
for P-Y654 and ßIII-tubulin colocalizating  at enlarged growth cones where 
microtubules unbundle and along the axon (arrows). P-Y654 immunostaining can also 
be observed along filopodial-like processes and axonal spread areas devoid of ßIII-
tubulin (arrowheads). (C) Confocal image of  neurons fixed by detergent fixation shows 
the double immunostaining for P-Y654 and F-actin (phalloidin). Similar to anti-ß-
catenin antibodies, anti-P-Y654 antibodies stain the cell body and neurite tips where P-
Y654 and F-actin colocalize (arrows). (D) ß-catenin and P-Y142 colocalize within the 
cytoplasm of neurons (arrows), whereas colocalization of Hoestch and anti-P-Y142 
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immunostaining shows that P-Y142 ß-catenin is found in the nucleus (arrowheads). (E) 
Anti-P-Y654 antibodies stain the cell membrane at cell contacts and the cytoplasm, but 
the nucleus (stained by Hoestch) is negative. Bars = 15 µm (A), 20 µm (B and C) and 
45 µm (D and E).  
 
Figure 8. ∆N-TCF4 abolishes the effect of HGF in axon growth and branching. (A) 
Hippocampal neurons transfected with EYFP and ∆N-TCF4, untreated or treated with 
BDNF, NT-3 and HGF (50 ng/ml). ∆N-TCF4 abolishes the axon growth induced by 
HGF, but not by BDNF or NT-3. Bar = 40 µm. (B) Quantification of axon length in 
EYFP- or EYFP plus ∆N-TCF4-expressing neurons normalized to the respective 
untreated control shows that HGF and Wnt-3a (used as positive control; 50 ng/ml) do 
not increase axon length in neurons expressing ∆N-TCF4, whereas NTs similarly 
stimulate axon growth in ∆N-TCF4-expressing or control neurons. (C) Quantification of 
axon branching in neurons expressing EYFP alone or EYFP and ∆N-TCF4 shows that 
the HGF-induced branching is inhibited by ∆N-TCF4 expression, whereas the BDNF 
and NT-3-induced effects are not affected. (n=5-7 experiments) * P≤0.05, ** P≤0.01, 
***P≤0.001, when comparing to the corresponding untreated controls; # P≤0.05, ## 
P≤0.01, ###P≤0.001, when comparing to the corresponding stimulated control.  
 
Figure 9. Model for the role of β-catenin tyrosine phosphorylation in axon growth 
and branching. Adhesion complexes are assembled at the plasma membrane of the cell 
body, axon and growth cone. β-catenin residue Y654 is found at the region that binds to 
N-cadherin, whereas β-catenin Y142 is in the α-catenin binding region (Aberle et al., 
1996; Lilien and Balsamo, 2005). α-catenin also binds to actin (Drees et al., 2005; 
Yamada et al., 2005). Trk and Met associate to a pool of β-catenin bound to N-cadherin 
and α-catenin. β-catenin phosphorylation by HGF/Met signalling at β-catenin Y142 
targets β-catenin to the nucleus, where it activates transcription by TCF4 to increase 
axon growth and branching. The detachment of P-Y142 β-catenin from the adhesion 
complex may imply dynamic regulation of Y654 phosphorylation, perhaps by Src 
family tyrosine kinases (Roura et al., 1999) and its dephosphorylation before nuclear 
translocation of P-Y142 β-catenin (according to the lack of nuclear immunostaining for 
P-Y654). β-catenin phosphorylation by NT/Trk signalling at β-catenin Y654 detaches β-
catenin from N-cadherin (Bamji et al., 2006; Huber and Weis, 2001; Lilien and 
Balsamo, 2005; Roura et al., 1999) and P-Y654 β-catenin associates with actin and 
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microtubules at the growth cone, possibly regulating the cytoskeleton to promote axon 
growth and branching. Note that whereas we demonstrate that β-catenin/α-catenin 
dissociate upon phosphorylation of β-catenin Y142,  the depicted β-catenin dissociation 
from N-cadherin upon Y654 phosphorylation is based on the references above. For 
simplicity, Met has been located at the cell body and Trk at the growth cone plasma 
membrane (N, N-cadherin; β, β-catenin; α, α-catenin; _ _ , F-actin; ….., microtubules). 
 
Supplemental Figure 1. Met (A) and ß-catenin (B) immunostainings colocalize 
intracellularly and at neurite tips (C; arrows). (D) Met immunostaining does not 
significantly colocalize with Hoestch nuclear staining (arrowheads). Bar = 45 µm. 
 
 29
 
References 
 Aberle, H., Schwartz, H., Hoschuetzky, H. and Kemler, R. (1996). Single 
amino acid substitutions in proteins of the armadillo gene family abolish their binding to 
alpha-catenin. J Biol Chem 271, 1520-6. 
 Arevalo, J. C. and Chao, M. V. (2005). Axonal growth: where neurotrophins 
meet Wnts. Curr Opin Cell Biol 17, 112-5. 
 Arimura, N. and Kaibuchi, K. (2007). Neuronal polarity: from extracellular 
signals to intracellular mechanisms. Nat Rev Neurosci 8, 194-205. 
 Ayala, R., Shu, T. and Tsai, L. H. (2007). Trekking across the brain: the 
journey of neuronal migration. Cell 128, 29-43. 
 Balsamo, J., Arregui, C., Leung, T. and Lilien, J. (1998). The nonreceptor 
protein tyrosine phosphatase PTP1B binds to the cytoplasmic domain of N-cadherin and 
regulates the cadherin-actin linkage. J Cell Biol 143, 523-32. 
 Balsamo, J., Leung, T., Ernst, H., Zanin, M. K., Hoffman, S. and Lilien, J. 
(1996). Regulated binding of PTP1B-like phosphatase to N-cadherin: control of 
cadherin-mediated adhesion by dephosphorylation of beta-catenin. J Cell Biol 134, 801-
13. 
 Bamji, S. X. (2005). Cadherins: actin with the cytoskeleton to form synapses. 
Neuron 47, 175-8. 
 Bamji, S. X., Rico, B., Kimes, N. and Reichardt, L. F. (2006). BDNF 
mobilizes synaptic vesicles and enhances synapse formation by disrupting cadherin-
beta-catenin interactions. J Cell Biol 174, 289-99. 
 Bamji, S. X., Shimazu, K., Kimes, N., Huelsken, J., Birchmeier, W., Lu, B. 
and Reichardt, L. F. (2003). Role of beta-catenin in synaptic vesicle localization and 
presynaptic assembly. Neuron 40, 719-31. 
 Benson, D. L. and Tanaka, H. (1998). N-cadherin redistribution during 
synaptogenesis in hippocampal neurons. J Neurosci 18, 6892-904. 
 Bosse, T., Ehinger, J., Czuchra, A., Benesch, S., Steffen, A., Wu, X., 
Schloen, K., Niemann, H. H., Scita, G., Stradal, T. E. et al. (2007). Cdc42 and 
phosphoinositide 3-kinase drive Rac-mediated actin polymerization downstream of c-
Met in distinct and common pathways. Mol Cell Biol 27, 6615-28. 
 Brembeck, F. H., Rosario, M. and Birchmeier, W. (2006). Balancing cell 
adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16, 51-
9. 
 Brembeck, F. H., Schwarz-Romond, T., Bakkers, J., Wilhelm, S., 
Hammerschmidt, M. and Birchmeier, W. (2004). Essential role of BCL9-2 in the 
switch between beta-catenin's adhesive and transcriptional functions. Genes Dev 18, 
2225-30. 
 Ciani, L. and Salinas, P. C. (2005). WNTs in the vertebrate nervous system: 
from patterning to neuronal connectivity. Nat Rev Neurosci 6, 351-62. 
 Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 
127, 469-80. 
 Coluccia, A. M., Vacca, A., Dunach, M., Mologni, L., Redaelli, S., Bustos, V. 
H., Benati, D., Pinna, L. A. and Gambacorti-Passerini, C. (2007). Bcr-Abl stabilizes 
beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. Embo J 
26, 1456-66. 
 30
 Collazo, D., Takahashi, H. and McKay, R. D. (1992). Cellular targets and 
trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron 9, 643-
56. 
 Chao, M. V. (2003). Neurotrophins and their receptors: a convergence point for 
many signalling pathways. Nat Rev Neurosci 4, 299-309. 
 Chen, T. J., Gehler, S., Shaw, A. E., Bamburg, J. R. and Letourneau, P. C. 
(2006). Cdc42 participates in the regulation of ADF/cofilin and retinal growth cone 
filopodia by brain derived neurotrophic factor. J Neurobiol 66, 103-14. 
 Dalva, M. B., McClelland, A. C. and Kayser, M. S. (2007). Cell adhesion 
molecules: signalling functions at the synapse. Nat Rev Neurosci 8, 206-20. 
 Danilkovitch-Miagkova, A., Miagkov, A., Skeel, A., Nakaigawa, N., Zbar, B. 
and Leonard, E. J. (2001). Oncogenic mutants of RON and MET receptor tyrosine 
kinases cause activation of the beta-catenin pathway. Mol Cell Biol 21, 5857-68. 
 Drees, F., Pokutta, S., Yamada, S., Nelson, W. J. and Weis, W. I. (2005). 
Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates 
actin-filament assembly. Cell 123, 903-15. 
 Elul, T. M., Kimes, N. E., Kohwi, M. and Reichardt, L. F. (2003). N- and C-
terminal domains of beta-catenin, respectively, are required to initiate and shape axon 
arbors of retinal ganglion cells in vivo. J Neurosci 23, 6567-75. 
 Espinet, C., Gomez-Arbones, X., Egea, J. and Comella, J. X. (2000). 
Combined use of the green and yellow fluorescent proteins and fluorescence-activated 
cell sorting to select populations of transiently transfected PC12 cells. J Neurosci 
Methods 100, 63-9. 
 Gallo, G. and Letourneau, P. C. (2004). Regulation of growth cone actin 
filaments by guidance cues. J Neurobiol 58, 92-102. 
 Gao, X., Arlotta, P., Macklis, J. D. and Chen, J. (2007). Conditional knock-
out of beta-catenin in postnatal-born dentate gyrus granule neurons results in dendritic 
malformation. J Neurosci 27, 14317-25. 
 Gehler, S., Shaw, A. E., Sarmiere, P. D., Bamburg, J. R. and Letourneau, P. 
C. (2004). Brain-derived neurotrophic factor regulation of retinal growth cone filopodial 
dynamics is mediated through actin depolymerizing factor/cofilin. J Neurosci 24, 
10741-9. 
 Goda, Y. (2002). Cadherins communicate structural plasticity of presynaptic 
and postsynaptic terminals. Neuron 35, 1-3. 
 Gould, T. D., O'Donnell, K. C., Picchini, A. M., Dow, E. R., Chen, G. and 
Manji, H. K. (2008). Generation and behavioral characterization of beta-catenin 
forebrain-specific conditional knock-out mice. Behav Brain Res 189, 117-25. 
 Govek, E. E., Newey, S. E. and Van Aelst, L. (2005). The role of the Rho 
GTPases in neuronal development. Genes Dev 19, 1-49. 
 Hecht, A., Litterst, C. M., Huber, O. and Kemler, R. (1999). Functional 
characterization of multiple transactivating elements in beta-catenin, some of which 
interact with the TATA-binding protein in vitro. J Biol Chem 274, 18017-25. 
 Hempstead, B. L., Rabin, S. J., Kaplan, L., Reid, S., Parada, L. F. and 
Kaplan, D. R. (1992). Overexpression of the trk tyrosine kinase rapidly accelerates 
nerve growth factor-induced differentiation. Neuron 9, 883-96. 
 Hiscox, S. and Jiang, W. G. (1999). Association of the HGF/SF receptor, c-
met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor 
cells. Biochem Biophys Res Commun 261, 406-11. 
 Honda, S., Kagoshima, M., Wanaka, A., Tohyama, M., Matsumoto, K. and 
Nakamura, T. (1995). Localization and functional coupling of HGF and c-Met/HGF 
 31
receptor in rat brain: implication as neurotrophic factor. Brain Res Mol Brain Res 32, 
197-210. 
 Hoschuetzky, H., Aberle, H. and Kemler, R. (1994). Beta-catenin mediates 
the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J 
Cell Biol 127, 1375-80. 
 Huang, E. J. and Reichardt, L. F. (2001). Neurotrophins: roles in neuronal 
development and function. Annu Rev Neurosci 24, 677-736. 
 Huang, E. J. and Reichardt, L. F. (2003). Trk receptors: roles in neuronal 
signal transduction. Annu Rev Biochem 72, 609-42. 
 Huber, A. H. and Weis, W. I. (2001). The structure of the beta-catenin/E-
cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. 
Cell 105, 391-402. 
 Iwasaki, Y., Gay, B., Wada, K. and Koizumi, S. (1998). Association of the Src 
family tyrosine kinase Fyn with TrkB. J Neurochem 71, 106-11. 
 Kalil, K. and Dent, E. W. (2005). Touch and go: guidance cues signal to the 
growth cone cytoskeleton. Curr Opin Neurobiol 15, 521-6. 
 Korhonen, L., Sjoholm, U., Takei, N., Kern, M. A., Schirmacher, P., 
Castren, E. and Lindholm, D. (2000). Expression of c-Met in developing rat 
hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing 
neurons. Eur J Neurosci 12, 3453-61. 
 Kypta, R. M., Su, H. and Reichardt, L. F. (1996). Association between a 
transmembrane protein tyrosine phosphatase and the cadherin-catenin complex. J Cell 
Biol 134, 1519-29. 
 Labelle, C. and Leclerc, N. (2000). Exogenous BDNF, NT-3 and NT-4 
differentially regulate neurite outgrowth in cultured hippocampal neurons. Brain Res 
Dev Brain Res 123, 1-11. 
 Lilien, J. and Balsamo, J. (2005). The regulation of cadherin-mediated 
adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin 
Cell Biol 17, 459-65. 
 Lindholm, D., Carroll, P., Tzimagiogis, G. and Thoenen, H. (1996). 
Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the 
neurotrophins BDNF, NT-3 and NT-4. Eur J Neurosci 8, 1452-60. 
 Logan, C. Y. and Nusse, R. (2004). The Wnt signaling pathway in development 
and disease. Annu Rev Cell Dev Biol 20, 781-810. 
 Lu, W., Yamamoto, V., Ortega, B. and Baltimore, D. (2004). Mammalian 
Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 119, 97-
108. 
 Luo, L. (2000). Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1, 
173-80. 
 Llovera, M., de Pablo, Y., Egea, J., Encinas, M., Peiro, S., Martin-Zanca, 
D., Rocamora, N. and Comella, J. X. (2004). Trk is a calmodulin-binding protein: 
implications for receptor processing. J Neurochem 88, 422-33. 
 Martinez, A., Alcantara, S., Borrell, V., Del Rio, J. A., Blasi, J., Otal, R., 
Campos, N., Boronat, A., Barbacid, M., Silos-Santiago, I. et al. (1998). TrkB and 
TrkC signaling are required for maturation and synaptogenesis of hippocampal 
connections. J Neurosci 18, 7336-50. 
 Miyamoto, Y., Yamauchi, J., Tanoue, A., Wu, C. and Mobley, W. C. (2006). 
TrkB binds and tyrosine-phosphorylates Tiam1, leading to activation of Rac1 and 
induction of changes in cellular morphology. Proc Natl Acad Sci U S A 103, 10444-9. 
 32
 Monga, S. P., Mars, W. M., Pediaditakis, P., Bell, A., Mule, K., Bowen, W. 
C., Wang, X., Zarnegar, R. and Michalopoulos, G. K. (2002). Hepatocyte growth 
factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-
catenin dissociation in hepatocytes. Cancer Res 62, 2064-71. 
 Moon, R. T., Kohn, A. D., De Ferrari, G. V. and Kaykas, A. (2004). WNT 
and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5, 691-701. 
 Morotti, A., Mila, S., Accornero, P., Tagliabue, E. and Ponzetto, C. (2002). 
K252a inhibits the oncogenic properties of Met, the HGF receptor. Oncogene 21, 4885-
93. 
 Murase, S., Mosser, E. and Schuman, E. M. (2002). Depolarization drives 
beta-Catenin into neuronal spines promoting changes in synaptic structure and function. 
Neuron 35, 91-105. 
 Nelson, W. J. and Nusse, R. (2004). Convergence of Wnt, beta-catenin, and 
cadherin pathways. Science 303, 1483-7. 
 Ozawa, M. and Kemler, R. (1998). Altered cell adhesion activity by 
pervanadate due to the dissociation of alpha-catenin from the E-cadherin.catenin 
complex. J Biol Chem 273, 6166-70. 
 Pante, G., Thompson, J., Lamballe, F., Iwata, T., Ferby, I., Barr, F. A., 
Davies, A. M., Maina, F. and Klein, R. (2005). Mitogen-inducible gene 6 is an 
endogenous inhibitor of HGF/Met-induced cell migration and neurite growth. J Cell 
Biol 171, 337-48. 
 Pereira, D. B. and Chao, M. V. (2007). The tyrosine kinase Fyn determines the 
localization of TrkB receptors in lipid rafts. J Neurosci 27, 4859-69. 
 Piedra, J., Martinez, D., Castano, J., Miravet, S., Dunach, M. and de 
Herreros, A. G. (2001). Regulation of beta-catenin structure and activity by tyrosine 
phosphorylation. J Biol Chem 276, 20436-43. 
 Piedra, J., Miravet, S., Castano, J., Palmer, H. G., Heisterkamp, N., Garcia 
de Herreros, A. and Dunach, M. (2003). p120 Catenin-associated Fer and Fyn 
tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-
catenin Interaction. Mol Cell Biol 23, 2287-97. 
 Piper, M. and Holt, C. (2004). RNA translation in axons. Annu Rev Cell Dev 
Biol 20, 505-23. 
 Rasola, A., Fassetta, M., De Bacco, F., D'Alessandro, L., Gramaglia, D., Di 
Renzo, M. F. and Comoglio, P. M. (2007). A positive feedback loop between 
hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell 
invasive growth. Oncogene 26, 1078-87. 
 Rhee, J., Buchan, T., Zukerberg, L., Lilien, J. and Balsamo, J. (2007). 
Cables links Robo-bound Abl kinase to N-cadherin-bound beta-catenin to mediate Slit-
induced modulation of adhesion and transcription. Nat Cell Biol 9, 883-92. 
 Rhee, J., Mahfooz, N. S., Arregui, C., Lilien, J., Balsamo, J. and 
VanBerkum, M. F. (2002). Activation of the repulsive receptor Roundabout inhibits N-
cadherin-mediated cell adhesion. Nat Cell Biol 4, 798-805. 
 Riehl, R., Johnson, K., Bradley, R., Grunwald, G. B., Cornel, E., 
Lilienbaum, A. and Holt, C. E. (1996). Cadherin function is required for axon 
outgrowth in retinal ganglion cells in vivo. Neuron 17, 837-48. 
 Roose, J., Huls, G., van Beest, M., Moerer, P., van der Horn, K., 
Goldschmeding, R., Logtenberg, T. and Clevers, H. (1999). Synergy between tumor 
suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285, 1923-6. 
 33
 Roura, S., Miravet, S., Piedra, J., Garcia de Herreros, A. and Dunach, M. 
(1999). Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J 
Biol Chem 274, 36734-40. 
 Royal, I., Lamarche-Vane, N., Lamorte, L., Kaibuchi, K. and Park, M. 
(2000). Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth 
factor differentially regulates epithelial cell colony spreading and dissociation. Mol Biol 
Cell 11, 1709-25. 
 Sadot, E., Simcha, I., Shtutman, M., Ben-Ze'ev, A. and Geiger, B. (1998). 
Inhibition of beta-catenin-mediated transactivation by cadherin derivatives. Proc Natl 
Acad Sci U S A 95, 15339-44. 
 Salinas, P. C. and Price, S. R. (2005). Cadherins and catenins in synapse 
development. Curr Opin Neurobiol 15, 73-80. 
 Sole, C., Dolcet, X., Segura, M. F., Gutierrez, H., Diaz-Meco, M. T., 
Gozzelino, R., Sanchis, D., Bayascas, J. R., Gallego, C., Moscat, J. et al. (2004). The 
death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that 
depends on ERK and NF-kapp B signaling. J Cell Biol 167, 479-92. 
 Tai, C. Y., Mysore, S. P., Chiu, C. and Schuman, E. M. (2007). Activity-
regulated N-cadherin endocytosis. Neuron 54, 771-85. 
 Takahashi, K., Suzuki, K. and Tsukatani, Y. (1997). Induction of tyrosine 
phosphorylation and association of beta-catenin with EGF receptor upon tryptic 
digestion of quiescent cells at confluence. Oncogene 15, 71-8. 
 Takeichi, M. (2007). The cadherin superfamily in neuronal connections and 
interactions. Nat Rev Neurosci 8, 11-20. 
 Theisen, C. S., Wahl, J. K., 3rd, Johnson, K. R. and Wheelock, M. J. (2007). 
NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor 
receptor to modulate the actin cytoskeleton and regulate cell motility. Mol Biol Cell 18, 
1220-32. 
 Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. 
Nat Rev Cancer 2, 442-54. 
 Uchida, N., Honjo, Y., Johnson, K. R., Wheelock, M. J. and Takeichi, M. 
(1996). The catenin/cadherin adhesion system is localized in synaptic junctions 
bordering transmitter release zones. J Cell Biol 135, 767-79. 
 Vicario-Abejon, C., Collin, C., McKay, R. D. and Segal, M. (1998). 
Neurotrophins induce formation of functional excitatory and inhibitory synapses 
between cultured hippocampal neurons. J Neurosci 18, 7256-71. 
 Xu, G., Arregui, C., Lilien, J. and Balsamo, J. (2002). PTP1B modulates the 
association of beta-catenin with N-cadherin through binding to an adjacent and partially 
overlapping target site. J Biol Chem 277, 49989-97. 
 Xu, G., Craig, A. W., Greer, P., Miller, M., Anastasiadis, P. Z., Lilien, J. 
and Balsamo, J. (2004). Continuous association of cadherin with beta-catenin requires 
the non-receptor tyrosine-kinase Fer. J Cell Sci 117, 3207-19. 
 Yamada, S., Pokutta, S., Drees, F., Weis, W. I. and Nelson, W. J. (2005). 
Deconstructing the cadherin-catenin-actin complex. Cell 123, 889-901. 
 Yamashita, T., Tucker, K. L. and Barde, Y. A. (1999). Neurotrophin binding 
to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 24, 585-93. 
 Ye, H., Kuruvilla, R., Zweifel, L. S. and Ginty, D. D. (2003). Evidence in 
support of signaling endosome-based retrograde survival of sympathetic neurons. 
Neuron 39, 57-68. 
 Yu, X. and Malenka, R. C. (2003). Beta-catenin is critical for dendritic 
morphogenesis. Nat Neurosci 6, 1169-77. 
 34
 Yu, X. and Malenka, R. C. (2004). Multiple functions for the cadherin/catenin 
complex during neuronal development. Neuropharmacology 47, 779-86. 
 Zampieri, N. and Chao, M. V. (2006). Mechanisms of neurotrophin receptor 
signalling. Biochem Soc Trans 34, 607-11. 
 Zhou, F. Q., Zhou, J., Dedhar, S., Wu, Y. H. and Snider, W. D. (2004). NGF-
induced axon growth is mediated by localized inactivation of GSK-3beta and functions 
of the microtubule plus end binding protein APC. Neuron 42, 897-912. 
 Zhou, P., Porcionatto, M., Pilapil, M., Chen, Y., Choi, Y., Tolias, K. F., 
Bikoff, J. B., Hong, E. J., Greenberg, M. E. and Segal, R. A. (2007). Polarized 
signaling endosomes coordinate BDNF-induced chemotaxis of cerebellar precursors. 
Neuron 55, 53-68. 
 
  
 









Table 1. Dendrite morphogenesis is not regulated by tyrosine phosphorylation of β-
catenin in 2 DIV hippocampal neurons. 
Dendrite length fold increase compared to control 
Treatment Average±s.e.m. Significance(n) 
Control 1 ± 0.12 N.S.* (n=11) 
BDNF 1.16  ± 0.13 N.S. (n=9) 
HGF 1.00  ± 0.07 N.S (n=6) 
 
Dendrite branching (Total Dendrite Branch Tip Number, TDBTN) compared to control 
Treatment Average±s.e.m. Significance(n) 
Control 3.37 ± 0.29 N.S. (n=11) 
BDNF 3.51 ± 0.48 N.S. (n=9) 
HGF 3.49 ± 0.79 N.S (n=6) 
*N.S. = not significant 
 
 
